Ads
related to: csl behring stockinvesco.com has been visited by 100K+ users in the past month
Search results
CSL Ltd's Dividend Analysis
GuruFocus.com via Yahoo Finance· 3 months agoCSL Ltd (CSLLY) recently announced a dividend of $0.6 per share, payable on a date yet to be announced, with the ex-dividend date set for 2024-03-11. As...
uniQure (QURE) Partner Gets FDA Nod for Hemophilia B Gene Therapy
Zacks via Yahoo Finance· 2 years agoShares of uniQure QURE were up 7.08% during market hours after the company announced that its...
The most expensive drug in the world has a $3.5 million price tag. 2 potential patients share their...
Business Insider via Yahoo News· 1 year agoBryen Lackey, 18, has the genetic bleeding disorder hemophilia B. He said he could be interested in...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 1 month agoThe Food and Drug Administration approved Pfizer's hemophilia B gene therapy on Friday, a one-time...
Australia's CSL prices hemophilia gene therapy at $3.5 million
Reuters via Yahoo News· 2 years ago(Reuters) -Australian drugmaker CSL Ltd on Tuesday set the list price of its one-time gene therapy...
uniQure (QURE) Up on Restructuring Plans, Workforce Reduction
Zacks via Yahoo Finance· 8 months agoShares of uniQure N.V. QURE were up 11.61% on Oct 5 after the company announced a strategic...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoPfizer stock is lingering just above its 50-day line after the company beat first-quarter sales...
Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback
Zacks via Yahoo Finance· 8 months agoIt was a busy week for the biotech sector. M&A is back in the spotlight in the sector as Bristol...
FDA Accepts Pfizer's (PFE) Hemophilia B Gene Therapy Filing
Zacks via Yahoo Finance· 11 months agoPfizer PFE announced that its regulatory submissions in the United States and European Union (“EU”)...
Why Shares of uniQure Are Up Thursday
Motley Fool· 8 months agoShares of uniQure (NASDAQ: QURE) were up more than 8% as of 1 p.m. after rising as much as 14% earlier in the day. The biggest move is that uniQure said...
